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having 3 or more ﬁnger joints affected by radiographic OA, and the
adjusted estimate remained similar in knees with KL grade 0 (n¼749)
(Table).ĂConclusions: Having multiple ﬁnger joints with radiographic OA is
associated with meniscal damage of the knee. The results suggest
a common systemic/genetic predisposition and (or) a common envi-
ronmental risk factor for radiographic hand OA andmeniscal damage in
the middle-aged and elderly.
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SYNOVIAL WNT AND WISP1 EXPRESSION INDUCES CARTILAGE
DAMAGE BY SKEWING OF TGF-BETA SIGNALING AND REDUCTION
OF THE ANTI-HYPERTROPHIC FACTOR SOX9
M.H. van den Bosch, A.B. Blom, P.L. van Lent, H.M. van Beuningen,
F.A. van de Loo, E.N. Blaney Davidson, P.M. van der Kraan, W.B. van
den Berg. Radboud Univ. Nijmegen Med. Ctr., NCMLS, Nijmegen,
Netherlands
Purpose: Although many osteoarthritis (OA) patients show signiﬁcant
synovial involvement, consequences are largely unknown. We found
highly induced expression of canonical Wnts 2b and 16 and Wnt-1
induced signaling protein 1 (WISP1), a downstream protein, in knee
joints in two experimental murine OA models. Wnt signaling has been
implicated in OA incidence and modulation of the b-catenin pathway
leads to OA-like changes in cartilage. In addition, TGF-b signaling is
critical in cartilage maintenance. TGF-b signals via both ALK5 and ALK1
and downstream via Smad 2/3 and Smad 1/5/8 respectively. In the
present study we investigated the potency of canonical Wnts, produced
in the synovium, to induce OA pathology and whether canonical Wnts
skew TGF-b signaling from the protective Smad 2/3 pathway towards
the Smad 1/5/8 pathway, which can induce chondrocyte hypertrophy.
Methods: Pathway analysis of microarray data from the synovium of
a collagenase-inducedOAmousemodelwas done usingDAVID software.
Detection of Smad 2/3 and Smad 1/5/8 phosphorylation was done by
Western blot analysis. In vivo synovial overexpression of genes from the
canonical Wnt signaling pathway was achieved by intra-articular
injectionof adenoviral vectors. Joint pathologywas assessedbyhistology
at several time points after injection. Gene expression was analyzed by
qPCRafteroverexpressionofWntgenes in isolatedhumanchondrocytes.
Results: Pathway analysis using DAVID bioinformatics, showed that
both the Wnt and TGF-b signaling pathway were enriched in the
synovium of mice with collagenase-induced OA. To determine if syno-
vial overexpression of canonical Wnts leads to cartilage damage, we
injected adenoviral vectors for Wnt8a and Wnt16 into murine knee
joints. These vectors speciﬁcally target synovial cells, because they are
too large to penetrate cartilage. A signiﬁcant induction of OA pathology
was found at the medial margin of the medial tibial plateau, the place
where the ﬁrst damage is often found in our OA models, 7 days after
overexpression. The incidence was 92% (n¼12) for Wnt8a over-
expression compared to 17% (N¼12) for the control virus and 80% (N¼5)
for Wnt16 overexpression, but only 20% (N¼5) for the control virus. In
addition, overexpression of Wnt16 led to signiﬁcantly increased syno-
vial cellularity, accompanied by increased cartilage pathology on the
lateral side of the femoral-tibial joint. Because of their relatively small
size, Wnts and WISP1 proteins can migrate into the cartilage and
possibly alter chondrocyte phenotype. Synovial overexpression of
Wnt8a and Wnt16 led to b-catenin accumulation in chondrocytes,
a tell-tale sign of canonical Wnt signaling, indicating diffusion of Wntsto the cartilage. Moreover, in vitro overexpression of canonicalWnts and
WISP1 in human chondrocytes led to a signiﬁcant increase of collagen
type I and a signiﬁcant decrease in type II collagen expression, sug-
gesting a loss of chondrocyte phenotype. Pre-incubation with Wnt3a or
WISP alone or Wnt3a + WISP1 together resulted in decreased TGF-b-
induced phosphorylation of Smad 2/3, whereas phosphorylation of
Smad 1/5/8 was increased in vitro. This implies a shift towards domi-
nant TGF-b signaling via the hypertrophy-inducing ALK1 pathway.
Moreover, on a functional level, the expression of the anti-hypertrophic
factor Sox9 was decreased after pre-incubation with Wnt3a and WISP1.
Conclusions: Canonical Wnts produced in the synovium may play an
important role in OA pathology by inducing b-catenin signaling in the
cartilage followed by cartilage damage. Synovial overexpression of
canonical Wnts, as is found in experimental OA, may lead to chon-
drocyte phenotype changes, probably via modulation of the important
TGF-b signaling pathway. This underlines that synovial Wnt/WISP1
expression may be a potential target for OA therapy.
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DISRUPTION OF SIRT1 IN CHONDROCYTES CAUSES ACCELERATED
DEVELOPMENT OF OSTEOARTHRITIS INDUCED BY JOINT
INSTABILITY IN THE MOUSE
T. Matsuzaki, T. Matsushita, S. Kubo, T. Matsumoto, H. Sasaki, K.
Takayama, M. Kurosaka, R. Kuroda. Kobe Univ. Graduate Sch. of Med.,
Kobe, Hyogo, Japan
Purpose: SIRT1 is a histone deacetylase that regulates gene expression
and protein function by deacetylating histone and non-histone
proteins. We previously reported that SIRT1 inhibits apoptosis of
human chondrocytes and the inhibition of SIRT1 in human chon-
drocytes caused osteoarthritic gene expression changes. However, the
role of SIRT1 in development of osteoarthritis (OA) is still unknown.
Especially its role has not beenwell examined in vivo. To investigate the
role of SIRT1 in vivo, chondrocyte-speciﬁc Sirt1-conditonal knockout
(CKO) mice were analyzed using an experimental OA model.
Methods: OA was mechanically induced by surgical transection of the
medial collateral ligament and resection of the medial meniscus under
a microscope using knee joints of C57BL/6J mice. Mice were sacriﬁced 2,
4 and 8 weeks after the surgery and the expression changes of Sirt1
during OA progression was examined by immunohistochemistry. To
examine the role of Sirt1 in chondrocytes in vivo, we generated Sirt1-
CKO mice in which Sirt1 was disrupted in chondrocytes using Col2a1-
Cre transgenic mice using Cre-loxP system (Sirt1ﬂox/ﬂox;Col2a1-Cre
mice). To further examine the role of Sirt1 in OA, OA was surgically
induced in Sirt1-CKO mice. The cartilage specimen was stained with
Safranin O/fast green. The histological OA gradewas evaluated using the
Osteoarthritis Research Society International cartilage OA histopa-
thology grading system. In addition, immunohistochemistry for
collagen X and ADAMTS-5 was performed.
Results: SIRT1 expressions were gradually reduced in the wild-type
mice 2, 4, and 8 weeks after surgery in associated with progression of
OA. Sirt1-CKO mice did not show obvious skeletal abnormalities.
However the histological OA score was signiﬁcantly higher in the Sirt1-
CKO mice compared with Sirt1ﬂox/ﬂox mice at 2 and 4 weeks. Immu-
nohistochmical analysis showed that both Collagen X and ADAMTS-5
was increased in Sirt1-CKO mice 2 weeks after surgery compared with
Sirt1ﬂox/ﬂox mice. Conclusions: We observed that an accelerated
development of OA induced by joint instability in the chondrocyte-
speciﬁc Sirt1-CKO mice. Our observations suggested that SIRT1 plays
a preventive role against development of OA.
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SYNDECAN-4 IS CRITICALLY INVOLVED IN INFLAMMATORY DRIVEN
BONE FRACTURE REPAIR, BUT NOT FETAL SKELETAL DEVELOPMENT
J. Bertrand 1, R. Stange 2, H. Hidding 2, F. Echtermeyer 3, G. Nalesso 1,
L. Godmann 4, F. Dell'Accio 1, T. Pap 4, R. Dreier 5. 1William Harvey Inst.,
London, United Kingdom; 2Dept. of Trauma, Hand and Reconstructive
Surgery, Muenster, Germany; 3Dept. of Anaesthesiology and Intensive
Care Med.,, Hanover, Germany; 4 Inst. for Experimental Musculoskeletal
Med., Muenster, Germany; 5 Inst. for Physiological Chemistry and
Pathobiochemistry, Muenster, Germany
Purpose: The heparan sulfate proteoglycan syndecan-4 (Sdc4) has been
associated with osteoarthritis (OA). OA is a disease that mimics key
Table 1
Results Summary
Baseline (3 months) Follow-up (2 years)
APM Control APM Control
Medial Tibial Cartilage Volume
(mm3)
1934384 NA 1864369* NA
Gait Speed (m/sec) 1.880.3 1.970.2 1.900.2 1.930.2
Medial Knee Load:
Peak KAM(Nm/BW*ht%) 2.81.2a 2.51.1 3.21.2* 2.61.3
Peak KAM Impulse(Nm.s/BW*ht%) 0.80.3a 0.60.3 0.80.3b 0.60.3
Isokinetic Strength @ 60/sec (Nm/kg):
Concentric Quadriceps 1.720.5a 2.060.4 1.940.4* 2.040.5
Eccentric Quadriceps 2.220.7a 2.610.7 2.420.7* 2.440.7
Concentric Hamstrings 0.960.3a 1.110.3 1.090.3* 1.150.3
Eccentric Hamstrings 1.370.4a 1.610.3 1.480.4* 1.500.4
ap<0.05 compared to control at baseline; bp<0.05 compared to control at follow-up;
*p<0.5 compared to APM at baseline; NA¼not assessed
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However, the role of Sdc4 in embryonic and adult bone formation has
not been elucidated. To investigate the role of Sdc4 in these processes,
we used Sdc4-/- mice to analyze the distribution and functional role of
Scd4 in endochondral ossiﬁcation of mouse embryos and in adult
fracture repair, which recapitulates endochondral ossiﬁcation, but like
osteoarthritis involves an inﬂammatory component.
Methods: Sdc4 promoter activity was anlysed in Sdc4-/-/LacZ knock-in
animals, using b-galactosidase stainings. E16.5 embyros were used for
histological (alcian blue/alizarin red) and immunohistological (PCNA,
Col10a1, ADAMTS-4, BC-3, Sdc2) stainings and the calciﬁed bone area
was quantiﬁed using whole mount stainings of these embryos. Histo-
logical (Masson-Goldner, alcian blue) and immunohistological (Col10a1,
Sdc2, PCNA) stainings at day 7, 14 and 28 fracture calli were performed.
Callus size and cartilage area were quantiﬁed using image J. Chon-
drocytes were isolated from neonatal knee joints and embyronal
cartilage. Proliferation was investigated using MTT assay. Gene
expression analysis for Sdc-2, Sdc-4 with and without stimulation using
TNFa and WNT3a was performed using quantitative RT-PCR.
Results: Sdc4 promoter activity was detectable in all stages of chon-
drocyte differentiation, and Sdc4 deﬁciency inhibited chondrocyte
proliferation both in vivo and in vitro. Moreover, aggrecan turn over in
the epiphysial cartilage was decreased transiently in vivo, but this did
not lead to a growth phenotype at birth. In contrast, fracture healing in
adult mice was markedly delayed in Sdc4-/- animals and accompanied
by increased callus formation. Analysing the discrepancy between the
mild embryonic and the severe adult phenotype, we found a compen-
satory up-regulation of Sdc2 in the developing cartilage of sdc4-/- mice
that was absent in adult tissue. Stimulation of chondrocytes withWnt3a
in vitro, led to an increased expression of Sdc2, while stimulation with
TNFa resulted in an up-regulation of Sdc4 but a decreased expression of
Sdc2.
Conclusions:We conclude that Sdc4 is functionally involved in endo-
chondral ossiﬁcation and that the loss of Sdc4 impairs adult fracture
healing due to the inhibition of compensatory mechanisms under
inﬂammatory conditions.
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ARTHROSCOPIC PARTIAL MEDIAL MENISCECTOMY IS ASSOCIATED
WITH HIGHER MEDIAL KNEE JOINT LOAD AND REDUCTIONS IN
MEDIAL ARTICULAR CARTILAGE VOLUME DESPITE TYPICAL KNEE
STRENGTH AT 2 YEARS POST-SURGERY
K.L. Bennell 1, T.V. Wrigley 1, F.M. Cicuttini 2, B.R. Metcalf 1, M. Hall 1,
A.R. Dempsey 3, P.M. Mills 3, R.S. Hinman 1, Y. Wang 2, D.G. Lloyd 3. 1 The
Univ. of Melbourne, Melbourne, Australia; 2Monash Univ., Melbourne,
Australia; 3Grifﬁth Univ., Queensland, Australia
Purpose: Arthroscopic partial meniscectomy (APM) is one of the most
common orthopaedic surgeries performed. Following APM, individuals
are considered to be at a higher risk to develop early-onset knee oste-
oarthritis (OA). A higher external knee adduction moment (KAM) and
reduced knee extensor strength have been described in persons with
recent APM surgery. It is speculated that impaired knee muscle strength
contributes to higher KAM in this cohort. The purpose of this study was
to compare gait, knee strength and medial tibial cartilage volume
between: a) individuals 3 months post-APM surgery and a comparable
healthy control group, b) individuals 2 years post-APM surgery and
a comparable healthy group, c)individuals 3 months post-APM surgery
(baseline) and 2 years post-APM surgery (follow-up). Speciﬁcally,
independent variables included: 1) peak KAM, 2) KAM impulse, 3)
isokinetic knee extensor and ﬂexor strength and, 4) medial tibial
articular cartilage volume.
Methods: Eighty-two participants with APM were assessed at baseline
(88% male; age 415yrs; BMI 27.3 4.0kg/m2) and 65 (79%) returned
at follow-up (86% male; age 416yrs; BMI 27.34.6kg/m2).Thirty-
eight healthy controls were assessed at baseline (84% male; age
417yrs; BMI 25.03.4kg/m2) and 23 (61%) returned at follow-up
(87% male; age 427yrs; BMI 25.53.4kg/m2). Gait (8-camera VICON,
3 AMTI force plates) and isokinetic knee muscle strength (KinCom
dynamometer) were assessed at baseline and follow-up in both
groups. Participants walked barefoot at their self-selected fast pace,
and the ﬁrst peak KAM and KAM impulse were calculated during
stance using inverse dynamics and averaged over ﬁve trials. Partici-
pants performed ﬁve maximal isokinetic quadriceps and hamstring
contractions with highest score recorded. Medial tibial cartilagevolume was determined from MRI in the APM cohort at baseline and
at follow-up. Between group differences were determined using
ANCOVA (gait parameters with gait speed included as covariate) and
ANOVA (strength) at each time-point. Paired t-tests determined
differences between within the APM group over time. Signiﬁcance was
set at p<0.05.
Results: In addition to differences between the APM and control group
at baseline and follow-up, differences were also observed within the
APM group over time (Table 1). In the APM group, peak KAM and KAM
impulse were signiﬁcantly elevated at 3 months, and KAM impulse was
signiﬁcantly higher at 2 years post-surgery compared to controls.
Furthermore, peak KAM increased over time (by 14%) from baseline to
follow-up in the APM group. At baseline, isokinetic quadriceps and
hamstring strength was signiﬁcantly weaker in the APM group as
compared to controls. However at follow-up, no differences in quadri-
ceps or hamstring strength existed between groups. For the APM group,
medial tibial cartilage volume was signiﬁcantly reduced by 3.5% over
time.
Conclusions: Our ﬁndings suggest that greater medial knee joint
loading compared to controls was present 3 months post-APM surgery
and it remained elevated 2 years later, despite recovery of weaker knee
muscle strength to control levels. Further, there was a reduction in
medial tibial cartilage volume in the APM cohort over this time. It is
possible that elevatedmedial knee joint loading contributed to cartilage
volume loss. Alternative neuromuscular factors to strength, or other
contributors, may be responsible for KAM parameters remaining higher
at 2 years post-surgery.33
EFFECTIVE KNOCK DOWN OF MMP13 BY INTRA-ARTICULAR
INJECTION OF SMALL INTERFERING RNA (SIRNA) IN MURINE
SURGICALLY INDUCED OSTEOARTHRITIS MODEL
R. Akagi 1, T. Sasho 1, M. Saito 1, N. Ikegawa 1, S. Mukoyama 1,
Y. Muramatsu 1, S. Yamaguchi 1, K. Nakagawa 2, K. Takahashi 1. 1Chiba
Univ. Hosp., Chiba, Japan; 2 Sakura Med. Ctr. Toho Univ. Hosp., Chiba, Japan
Purpose: In the pathogenesis of osteoarthritis (OA), several
proteases including the MMP (matrix metalloproteinase) family
and ADAMTS (a disintegrin and metalloprotease with thrombo-
spondin motifs) family are thought to play a part in the early phase
of cartilage degradation. Among them, MMP13 is presumed to be
one of the major players, and inhibition of this protease has been
demonstrated to prevent cartilage degradation in animal osteoar-
thritic models. However, there is no conﬁrmed effective method to
safely achieve suppression of these enzymes postnatally in vivo.
The RNA interference (RNAi) technique using small interfering
RNAs (siRNAs) has been proven to be beneﬁcial in knocking down
protease effects in vitro, but there are still unsolved problems
before applying this method in vivo, due to the molecular insta-
bility and difﬁculty in transfecting siRNAs in vivo. Recently,
chemically modulated siRNAs which do not require transfection
agents or other additional techniques such as electroporation in
transfecting into cells have been developed. These siRNAs can be
applied simply to cells with low cellular toxicity, and is likely to be
suitable for in vivo use.
